Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

p53 might be useful to distinguish Langerhans cell hyperplasia from Langerhans cell histiocytosis

March 10, 2016

Acetazolamide counters effects of Klotho hypomorphism on aging

Jan. 20, 2016

Eagle Pharmaceuticals reports phase II results for dantrolene in exertional heat stroke

Dec. 22, 2015

Tocopherol-conjugated DNA/RNA heteroduplex oligonucleotides enhance brain and liver targeting

Nov. 5, 2015

TiGenix receives E.U. grant to support trial of Cx-611 in severe sepsis

Nov. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...